Zhejiang Lanyu Digital Technology
301585
BBK Test Systems
301598
MEIZHIGAO
834765
Youkeshu Technology
300209
Hangzhou Raycloud Technology Co.,Ltd
688365
CN Stock MarketDetailed Quotes
688428 InnoCare Pharma
- 12.61
- -0.23-1.79%
Market Closed Dec 20 15:00 CST
22.23BMarket Cap-59.20P/E (TTM)
12.97High12.39Low60.73KlotVolume12.89Open12.84Pre Close76.49MTurnover2.28%Turnover RatioLossP/E (Static)1.76BShares15.1552wk High3.27P/B3.36BFloat Cap7.2852wk Low15.41Limit Up266.28MShs Float16.99Historical High10.27Limit Down4.52%Amplitude7.28Historical Low--Dividend TTM12.59Avg Price32.31KlotAsk--Div YieldTTM100Lot Size26.49KlotBid
InnoCare Pharma Key Stats
EPS
According to the latest financial report of InnoCare Pharma, the latest earnings per share (TTM) for the company is -0.16. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out InnoCare Pharma's latest financial report to see how much their book value per share (BVPS) is currently at 3.86.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of InnoCare Pharma shows that the company's current ratio is 7.74, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of InnoCare Pharma, the quick ratio is 7.65, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of InnoCare Pharma? The latest ROE figure is -3.95%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of InnoCare Pharma, the total asset return on investment (ROA) is -2.94%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check InnoCare Pharma's latest financial report to see how their gross margin is doing - currently at 85.95%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of InnoCare Pharma, the net profit margin is -40.89%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.